510(k) Report

510(k) · Cleared

Cleared

Endoserter

K090626510(k) TraditionalCleared Jan 21, 2011683-day reviewClass I21 CFR 886.4300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ocular Systems, Inc. · OTZ Graft Insertion Instrument For Endothelial Keratoplasty

Cleared on Jan 21, 2011 after a 683-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 3 later devices descend from it.

Decided
Jan 21, 2011
Review
683 days
Class
Class I
Product code
OTZ
Recalls
None
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2011: 1 descendant cleared2022: 1 descendant cleared2010201520202025
  1. This deviceK090626 EndoserterOcular Systems, Inc. · 2011
  2. Descendant · cites it directly · 1 of its ownK121579 EK Delivery DeviceTdak Medical, Inc. · 2012
  3. Descendant · 2 generations on · 0 of its ownK203586 EndoSerter-PLCorneagen, Inc. · 2022
  4. Descendant · cites it directly · 0 of its ownK102999 Trimotion InjectorKaneka Corp. · 2011

Most influential descendants

Showing 3 of 3 · See all
  • K121579EK Delivery DeviceTdak Medical, Inc. · 2012 · cites it directly1descendant
  • K203586EndoSerter-PLCorneagen, Inc. · 2022 · 2 generations on0descendants
  • K102999Trimotion InjectorKaneka Corp. · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K090626EndoserterOcular Systems, Inc.2011—
+1K121579EK Delivery DeviceTdak Medical, Inc.2012—
+2K203586EndoSerter-PLCorneagen, Inc.2022—
+1K102999Trimotion InjectorKaneka Corp.2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201210
202210
FIG. 1 — Lineage of K090626, 2011–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OTZ device

  1. #1 K203586 EndoSerter-PLscore 3.1 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K121579EK Delivery DeviceTdak Medical, Inc.20121
K102999Trimotion InjectorKaneka Corp.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K121579 (Tdak Medical, Inc., 2012) has gone furthest, with 1 descendant of its own.

How does its category compare?

All OTZ devices

OTZ Graft Insertion Instrument For Endothelial Keratoplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · OTZ

1in 2022

2011: 22012: 22022: 1
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OTZ

Too few OTZ 510(k)s in any year since 2007 to give a median.

Recalls per year · OTZ

No recall names OTZ since 2007.

Adverse event reports per year · OTZ

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2025

MAUDE reports naming product code OTZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20112—00
20122—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

The EndoSerter™ is used to insert corneal endothelial allograft tissue measuring less than or equal to 8.5mm in diameter and 175 micron in central thickness into the anterior chamber through a minimum 4mm incision during endothelial keratoplasty procedures.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K090626: Endoserter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090626

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026